Mizar announces its Much-Requested Token Generation Event
LONDON, Feb. 20, 2023 (GLOBE NEWSWIRE) -- Following the successful completion of seed and private rounds and 9 figures
Globe Newswire21-02-2023, 05:36
Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancers 23-04-2025, 14:30